-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Article source: Medical Rubik's Cube Info
Recently, Tasly registered a Phase III clinical study on the prevention and treatment of acute altitude sickness (AMS) with T89 (Compound Danshen Dripping Pills) on the American Clinical Network
According to Tasly’s announcement, the prevention and treatment of acute altitude sickness (AMS) is a new indication discovered in many real-world clinical observations of T89
The compound Danshen dripping pill is a modern and innovative Chinese compound medicine developed exclusively by Tasly, which is mainly used for the prevention and treatment of cardiovascular diseases.
After that, Tasly submitted the new drug application (NDA) related approval information for T89 treatment of CSA to the FDA, and held a meeting with the FDA
Acute altitude sickness (AMS) is a common hypoxic disease that is unique to altitude.
T89 is the world's first Chinese compound medicine to apply for new drug listing in the United States